Nefrología : publicación oficial de la Sociedad Española Nefrologia
-
Randomized Controlled Trial
Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
Hemodialysis systems are potentially thrombogenic, so it is routinely used anticoagulation. Its prescription is with risks though which the recommendations regarding the scheduled dose are still based on very different criteria. ⋯ We demonstrate the low thrombogenicity of the AN69ST®; dialyzer that allows post-dilution hemodiafiltration sessions without systemic anticoagulation, and without increasing the frequency of severe clotting events compared to HF80®; dialyzer with nadroparin and with less risk of bleeding by not modifying the anti-Xa factor activity.